Further studies with 5E and 5Z analogues of PGI2 in platelets and vasculature.
Oliva
D
D
Institute of Pharmacological Sciences, Milan, Italy.
Giovanazzi
S
S
Lograno
M
M
Mongelli
N
N
Corsini
A
A
Fumagalli
R
R
Nicosia
S
S
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000527:Alprostadil / Q000494:pharmacology*; D000818:Animals; D001792:Blood Platelets / Q000201:enzymology*; D002462:Cell Membrane / Q000201:enzymology; D002478:Cells, Cultured; D011464:Epoprostenol / Q000494:pharmacology* / Q000031:analogs & derivatives; D007536:Isomerism; D008638:Mesenteric Arteries / Q000187:drug effects / Q000201:enzymology; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000201:enzymology*; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D011817:Rabbits
D010975:Platelet Aggregation Inhibitors; C026678:carboprostacyclin; D011464:Epoprostenol; D000262:Adenylyl Cyclases; D000527:Alprostadil